![](/img/cover-not-exists.png)
A 3 mg/kg starting dose of infliximab in active spondyloarthritis resistant to conventional treatments is efficient, safe and lowers costs
Ginette Tenga, Vincent Goëb, Thierry Lequerré, Hélène Bacquet-Deschryver, Alain Daragon, Sophie Pouplin, Karine Lanfant-Weybel, Xavier Le Loët, Bernard Dieu, Olivier VittecoqVolume:
78
Year:
2011
Language:
english
Pages:
6
DOI:
10.1016/j.jbspin.2010.04.017
File:
PDF, 178 KB
english, 2011